GPC-3 is a transmembrane heparan sulfate proteoglycan that regulates cell growth by tissue-dependent cellular signaling [86]; as its expression is increased in liver cancers, it has been used as a tumor maker and currently in ex vivo gene therapy to modify CAR-T to target HCC [87,88]. Here, GPC3 is linked to liver cancer.